Impaired vasodilator function in hypertension: The role of alterations in receptor-G protein coupling

Trends in Cardiovascular Medicine

Volumn 8, Issue 7, 1998, Pages 297-305

  Feldman, Ross D ^a   Gros, Robert ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN;

ENZYME ACTIVATION; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 0032191117     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00022-X     Document Type: Article

References (125)

1. Amer M.S., Gomoll A.W., Perhach J.L. Jr., Ferguson H.C., McKinney G.R. Aberrations of cyclic nucleotide metabolism in the hearts and vessels of hypertensive rats. Proc Natl Acad Sci USA. 71:1974;4930-4934.
2. Amerini T.C., Mantelli L., Filippi S., Ledda F. Effect of aging and hypertension on vasorelaxant activity of calcitonin gene-related peptide. a comparison with other vasodilator agents J Cardiovasc Pharmacol. 23:1994;432-437.
3. Anand-Srivastava M.B. Altered responsiveness of adenylate cyclase to adenosine and other agents in the myocardial sarcolemma and aorta of spontaneously-hypertensive rats. Biochem Pharmacol. 37:1988;3017-3022.
4. Anand-Srivastava M.B. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Biochem J. 288:1992;79-85.
5. Anand-Srivastava M.B. G-proteins and adenylyl cyclase signalling in hypertension. Mol Cell Biochem. 157:1996;163-170.
6. Angus J.A. Role of the endothelium in the genesis of cardiovascular disease. Clin Exp Pharmacol Physiol. 23:1996;S16-S22.
7. Arribas S., Marin J., Pointe A., Balfagon G., Salaices M. Norepinephrine-induced relaxations in rat aorta mediated by endothelial β adrenoceptors. Impairment by ageing and hypertension. J Pharmacol Exp Ther. 270:1994;520-527.
8. Arvola P., Ruskoaho H., Wuorela H., Pekki A., Vapaatalo H., Porsti E. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats. Br J Pharmacol. 108:1993;980-990.
9. Asano M., Okia K., Matsuda T. Reduced β adrenoceptor interactions of norepinephrine enhance contraction in the femoral artery from spontaneously hypertensive rats. J Pharmacol Exp Ther. 223:1982;207-214.
10. Asano M., Masuzawa K., Matsuda T. Evidence for reduced β-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats. Br J Pharmacol. 94:1988;73-86.
11. Bell D.R. Vascular smooth muscle responses to endothelial autacoids in rats with chronic coarctation hypertension. J Hypertens. 11:1993;65-74.
12. Bell D.R., Dec E.M., Rensberger H.J. Selective effect of high arterial pressure in hypertension upon inhibition of cGMP versus cAMP mediated vascular relaxation. Clin Exp Hypertens. 18:1996;773-791.
13. Bhalla R.C., Ashley T. Altered function of adenylate cyclase in the myocardium of the spontaneously hypertensive rat. Biochem Pharmacol. 27:1978;1967-1971.
14. Bhalla R.C., Sharma R.V. Characteristics of hormone-stimulated adenylate cyclase in vascular smooth muscle. altered activity in spontaneously hypertensive rat Blood Vessels. 19:1982;109-116.
15. Bhalla R.C., Sharma R.V., Ashley T. Adenylate cyclase activity in myocardium of spontaneously hypertensive rat. effect of endogenous factors and solubilization Biochem Biophys Res Commun. 82:1978;273-280.
16. Bhalla P.C., Sharma R.V., Ramanathan S. Ontogenetic development of isoproterenol subsensitivity of myocardial adenylate cy-clase and β-adrenergic receptors in spontaneously hypertensive rats. Biochem Biophys Acta. 682:1980;497-506.
17. 2+ J Cardiovasc Pharmacol. 27:1996;27-32.
18. Blumenthal S.J., McConnaughey M.M., Iams S.G. Myocardial adrenergic receptors and adenylate cyclase in the developing spontaneously hypertensive rat. Clin Exp Hypertens A. 4:1982;883-901.
19. iα in cardiac hypertrophy due to acquired hypertension. Hypertension. 20:1992;103-112.
20. Böhm M., Gierschik P., Knorr A., Schmidt U., Weismann K., Erdmann E. Cardiac adenylyl cyclase, β-adrenergic receptors and G proteins in salt-sensitive hypertension. Hypertension. 22:1993;715-727.
21. Böhm M., Grabel C., Knorr A., Erdmann E. Treatment in hypertension cardiac hypertrophy, I. Neuropeptide Y and β-adrenoceptors. Hypertension. 25:1995;954-961.
22. Boonen H.C.M., Daemen M.J.A.P., Eerdmans P.H.A.et al. Mesenteric small artery changes after vasoconstrictor infusion in young rats. J Cardiol Pharmacol. 22:1993;388-395.
23. Borkowski K.R., Porter M. An altered β-adrenoreceptor-mediated modulation of noradrenaline-induced vasoconstriction in spontaneously hypertensive rate mesenteric arteries. J Auton Pharmacol. 4:1984;27-31.
24. 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 35:1989;295-303.
25. Cauvin C., Pegram B. Decreased relaxation of isolated mesenteric resistance vessels from 2-kidney, 1 clip Goldblatt hypertensive rats. Clin Exp Hypertens A. 5:1983;383-400.
26. Carvalho M.H.C., Scivoletto R., Fortes Z.B., Nigro D., Cordellini S. Reactivity of aorta and mesenteric microvessels to drugs in spontaneously hypertensive rats. role of the endothelium J Hypertens. 5:1987;377-382.
27. Chatelain P., Robberecht P., De Neef P., Claeys M., Christophe J. Low responsiveness of cardiac adenylate cyclase activity to peptide hormones in spontaneously hypertensive rats. FEBS Lett. 107:1979;86-90.
28. Chatelain P., Robberecht P., De Neef P., Camus J.C., Heuse D., Christophe J. Secretin and VIP-stimulated adenylate cyclase from rat heart. Eur J Physiol. 389:1980;29-35.
29. Chatelain P., Waelbroeck M., Camus J.C.et al. Comparative effects of α-methyldopa propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats. Eur J Pharmacol. 72:1981;17-25.
30. Cheng J.B., Shibata S. Vascular relaxation in the spontaneously hypertensive rat. J Cardiovasc Pharmacol. 3:1981;1126-1140.
31. Chiu T.H. Age-dependent changes in the myocardial adenylate cyclase of normotensive and spontaneously hypertensive rat. Pharmacology. 22:1981;183-188.
32. Clark C.J., Milligan G., McLellan A.R., Connell J.M.C. Quanine nucleotide regulatory protein levels and function in spontaneously hypertensive rat vascular smooth-muscle cells. Biochem Biophys Acta. 1136:1992;290-296.
33. Clark C.J., Milligan C.J., Connell J.M.C. Guanine nucleotide regulatory protein alterations in the Milan hypertensive rat strain. J Hypertens. 11:1993;1161-1169. a.
34. Clark C.J., Milligan G., McLellan A.R., Connell J.M.C. Guanine nucleotide regulatory proteins in the spontaneously hypertensive rat. Hypertension. 21:1993;204-209. b.
35. Clark C.J., Milligan G., Connell J.M.C. Guanine nucleotide regulatory protein alterations in young Milan hypertensive strain rats. Biochem Biophys Acta. 1225:1994;149-157.
36. Cohen M.L., Berkowitz B.A. Decreased vascular relaxation in hypertension. J Pharmacol Exp Ther. 196:1976;396-406.
37. Cooke J.P., Dzau V.J. Nitric oxide synthase. role in the genesis of vascular disease Ann Rev Med. 48:1997;489-509.
38. Dadkar N.K., Aroskar V.A., Dohadwalla A.N. Peripheral vascular smooth muscle relaxation in normotensive and hypertensive rats. J Pharm Pharmacol. 32:1980;74-76.
39. 2-adrenoceptors of the portal veins of hypertensive rats. J Hypertens. 13:1995;1023-1029.
40. Felder R.A., Kinoshita S., Sidhu A., Ohbu K., Kaskel F.J. A renal dopamine-1 receptor defect in two genetic models of hypertension. Am J Hypertens. 3:1990;96S-99S.
41. 1 receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats. Am J Physiol. 264:1993;R726-R732.
42. Feldman R.D. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest. 85:1990;647-652. a.
43. Feldman R.D. β-Adrenoceptor responsiveness in hypertension. effects of dietary NaCl intake Br J Clin Pharmacol. 30:1990;55S-60S. b.
44. Feldman R.D. A low sodium diet corrects the defect in β-adrenergic response in older subjects. Circulation. 85:1992;612-618.
45. Feldman R.D., Chorazyczewski J. G-protein function is reduced in hypertension. Hypertension. 29:1997;422-427.
46. Feldman R.D., Limbird L.E., Nadeau J., Robertson D., Wood A.J.J. Leukocyte β receptor alterations in hypertensive subjects. J Clin Invest. 73:1984;648-653.
47. Feldman R.D., Lawton W.J., McArdle W.L. A low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects. J Clin Invest. 79:1987;290-294.
48. Feldman R.D., Freeman D.J., Bierbrier G.S., Anthony S.E., Brown J.E. β-Adrenergic responsiveness is regulated selectively in hypertension. Clin Pharmacol Ther. 54:1993;654-660.
49. Feldman R.D., Tan C.M., Chorazyczewski J. G-protein alterations in hypertension and aging. Hypertension. 26:1995;725-728.
50. Ferguson S.G., Barak L.S., Zhang J., Caron M.G. G-protein-coupled receptor regulation. role of G-protein-coupled receptor kinases and arrestins Can J Physiol Pharmacol. 74:1996;1095-1108.
51. Field F.P., Soltis E.E. Vascular reactivity in the spontaneously hypertensive rat. Effect of high pressure stress and extracellular calcium. Hypertension. 7:1985;228-235.
52. Freissmuth M., Kraupp O., Hausleithner V., Tuisl E., Schutz W. Alterations of the glomerular β-adrenoceptor-linked adenylate cyclase system in perinephritis hypertension. J Cardiovasc Pharmacol. 8:1986;60-66.
53. Fukuda N., Honda M., Minato M., Soma M., Izumi Y., Hatano M. Adenylate cyclase activities of vascular smooth muscle in early and established doca/salt hypertensive rats. Jpn Circ J. 34:1990;82-88.
54. Fujimoto S., Dohi Y., Aoki K., Asano M., Matsuda T. Diminished β-adrenoceptor-mediated relaxation of arteries from spontaneously hypertensive rats before and during development of hypertension. Eur J Pharmacol. 136:1987;179-187.
55. Fujimoto S., Dohi Y., Aoki K., Matsuda T. Altered vascular beta adrenoceptor-mediated relaxation in deoxycorticosterone-salt hypertensive rats. J Pharmacol Exp Ther. 244:1988;716-723. a.
56. 2-adrenoceptor-mediated relaxation responses in peripheral arteries from spontaneously hypertensive rats at prehypertensive and early hypertensive stages. J Hypertens. 6:1988;543-550. b.
57. Godfraind T., Dieu D. Influence of ageing on the isoprenaline relaxation of aortae from normal and hypertensive rats. Arch Int Pharmacodyn Ther. 236:1978;300-302.
58. Grammas P., Diglio C., Giacomelli F., Wiener J. Growth properties and receptor hypertension in vascular smooth muscle cells from hypertensive rats. Clin Exp Hypertens. 16:1994;207-227.
59. Gros R., Borkowski K.R., Feldman R.D. Human insulin-mediated enhancement of vascular β-adrenergic responsiveness. Hypertension. 23:1994;551-555.
60. Gros R., Benovic J.L., Tan C., Feldman R.D. G-protein coupled receptor-kinase activity is increased in hypertension. J Clin Invest. 99:1997;2087-2093. a.
61. Gros R, Chorazyczewski J, Benovic JL, Kelvin DJ, Feldman R: 1997b. G-protein receptor regulation in hypertension [abst]. Circulation 96:I-614.
62. 2+ uptake induced by isoprenaline in DOCA-salt pretreated rats. Drug Res. 34:1984;26-29.
63. Hagen E.C., Webb R.C. Coronary artery reactivity in deoxycorticosterone acetate hypertensive rats. Am J Physiol. 247:1984;H409-H414.
64. Hodgins D.S., Frohlich E.D. Cardiac adenylate cyclase, cyclic nucleotide phosphodiesterase and lactate dehydrogenase in normotensive and spontaneously hypertensive rats. Biochem Pharmacol. 27:1978;1179-1185.
65. Insel P.A. Adrenergic receptors - evolving concepts and clinical implications. N Engl J Med. 29:1996;580-585.
66. Jazayeri A., Meyer W.J. III Beta-adrenergic receptor differences in cultured arterial smooth muscle cells between spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens. 7:1989;895-900.
67. Kähönen M., Mäkynen H., Arvola P., Pörsti I. Enhancement of arterial relaxation by long-term atenolol treatment in spontaneously hypertensive rats. Br J Pharmacol. 112:1994;925-933.
68. Kamikawa Y., Cline W.H. Jr., Su C. Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur J Pharmacol. 66:1980;347-353.
69. Katovich M.J., Soltis E.E., Iloeje E., Field F.P. Time course alterations in vascular adrenergic responsiveness in the DOCA/NaCl-treated rat. Pharmacology. 29:1984;173-180.
70. Kawasaki H., Saito A., Takasaki K. Age-related decrease of calcitronin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat. Circ Res. 67:1990;733-743.
71. Kawasaki H., Saito A., Goto K., Takasaki K. Age-related changes in calcitronin gene-related peptide (CGRP)-mediated neurogenic vasodilation of the mesenteric resistance vessel in SHR. Clin Exp Hypertens A. 13:1991;745-754.
72. Kinoshita S., Sidhu A., Felder R.A. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest. 84:1989;1849-1856.
73. Klenerová V., Albrecht I., Hynie S. The activity of adenylate cyclase and phosphodiesterase in hearts and aortas of spontaneous hypertensive rats. Pharmacol Res Commun. 7:1975;453-462.
74. Koch W.J., Rockman H.A., Sarmama P.et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 268:1995;1350-1353.
75. Konishi M., Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension. 5:1983;881-886.
76. Lai F.M., Tanikella T., Thibault L., Chan P.S., Cervoni P. Effects of different stages of aortic coarctation hypertension on aortic contraction and relaxation in rats. J Pharmacol Exp Ther. 214:1980;388-394.
77. Levine G.N., Keaney J.F. Jr., Vita J.A. Cholesterol reduction in cardiovascular disease. N Engl J Med. 332:1995;512-521.
78. Limas C., Limas C.J. Up-regulation of renal prostaglandin receptors in genetic salt-dependent hypertension. Hypertension. 8:1986;566-571.
79. Lograno M.D., Daniele E., Galli C. Changes of vascular smooth muscle reactivity in hypertensive rats. Pharmacol Res. 21:1989;719-728.
80. Mäkynen H., Kähönen M., Arvola P., Wuorela H., Vapaatalo H., Pörtsi I. Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity. Br J Pharmacol. 115:1995;1455-1462.
81. Marcil J., Thibault C., Anand-Srivastava M.B. Enhanced expression of GI-protein procedes the development of blood pressure in spontaneously hypertensive rats. J Mol Cell Cardiol. 29:1997;1009-1022.
82. Masuzawa K., Matsuda T., Asano M. Decreased arterial responsiveness to multiple cyclic AMP-generating receptor agonists in spontaneously hypertensive rats. Br J Pharmacol. 96:1989;227-235.
83. McLellan A.R., Milligan G., Houslay M.D., Connell J.M.C. G-proteins in experimental hypertension. a study of spontaneously hypertensive rat myocardial and renal cortical plasma membranes J Hypertens. 11:1993;365-372.
84. Michel M.C., Brodde O.-E., Insel P.A. Peripheral adrenergic receptors in hypertension. Hypertension. 16:1990;107-120.
85. 2-, and β-adrenergic receptors and their signalling. Hypertension. 22:1993;169-177.
86. Mills P.J., Ziegler M.G., Nelesen R.A., Kennedy B.P. The effects of the menstrual cycle, race and gender. on adrenergic receptors and agonists Clin Pharmacol Ther. 60:1996;99-104.
87. Murakami T., Katada T., Yasuda H. Reduction in the activity of the stimulatory guanine nucleotide-binding protein in the myocardium of spontaneously hypertensive rats. Mol Cell Cardiol. 19:1987;199-208.
88. Naslund T., Silberstein D.J., Merrell W.J., Nadeau J.H., Wood A.J.J. Low sodium intake corrects abnormality in β-receptor-mediated arterial vasodilation in patients with hypertension. correlation with β-receptor function in vitro Clin Pharmacol Ther. 48:1990;87-95.
89. Nishimura Y., Usui H., Suzuki A., Kajimoto N., Yamanishi Y. Relaxant response of isolated basilar arteries to calcitonin gene-related peptide in stroke-prone spontaneously hypertensive rats. Jpn J Pharmacol. 59:1992;333-338.
90. Ohbu K., Felder R.A. Nephron specificity of dopamine receptor-adenylyl cyclase defect in spontaneous hypertension. Am J Physiol. 264:1993;F274-F279.
91. Ohbu K., Kaskel F.J., Kinoshita S., Felder R.A. Dopamine-1 receptors in the proximal convoluted tubule of Dahl rats. defective coupling to adenylate cyclase Am J Physiol. 268:1995;R231-R235.
92. Ohsuzu F., Katsushika S., Maie S.-I.et al. Enhanced myocardial adenylate cyclase activity in spontaneously hypertensive rats. Jpn Circ J. 56:1992;301-309.
93. Palmer G.C., Greenberg S. Alterations in myocardial adenylate cyclase in spontaneously hypertensive rats. Pharmacology. 19:1979;156-162.
94. Ping P., Li A., Bentley C., Hammond H.K. Increased G-protein receptor kinase activity and expression during development of heart failure [abst]. Circulation. 92:1995;57.
95. 2-adrenergic receptors. J Biol Chem. 268:1993;3201-3208.
96. Ramanathan S., Shibata S. Cyclic AMP blood vessels of spontaneously hypertensive rat. Blood Vessels. 11:1974;312-318.
97. Robberecht P., Winand J., Chatelain P.et al. Comparison of β-adrenergic receptors and adenylylate cyclase system with muscarinic receptors and guanylate cyclase activities in the heart of spontaneously hypertensive rats. Biochem Pharmacol. 30:1981;385-387.
98. Schütz W., Steurer G., Tuisl E., Kraupp O. The cardiac and brain microvessel adenylate cyclase system in deoxycorticosterone acetate-hypertensive rats. J Cardiol Pharmacol. 6:1984;325-330.
99. Shibata S., Cheng J.B. Vascular relaxation in hypertensive rats. Vanhoutte P.M., Leusen I. Mechanisms of Vasodilatation. 1978;181-186 Karger, Basel.
100. Sim M.K., Chua M.E. Altered responsiveness of the aorta of hypertensive rats to histamine and acetylcholine. Jpn J Pharmacol. 39:1985;551-553.
101. Soltis E.E., Bohr D.F. Cerebral vascular responsiveness in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol. 252:1987;H198-H203. a.
102. Soltis E.E., Bohr D.F. Vascular reactivity in the spontaneously hypertensive stroke-prone rat. Effects of antihypertensive treatment. Hypertension. 9:1987;492-497. b.
103. Soltis E.E., Field E.P. Effect of high blood pressure stress on vascular adrenergic responsiveness in the spontaneously hypertensive rat. Clin Exp Hypertens A. 6:1984;1237-1255.
104. Soltis E.E., Field E.P. Extracellular calcium and altered vascular responsiveness in the deoxycorticosterone acetate-salt rat. Hypertension. 8:1986;526-532.
105. Soltis E.E., Katovich M.J. Reduction in aortic smooth muscle beta-adrenergic responsiveness results in enhanced norepinephrine responsiveness in the Dahl salt-sensitive rat. Clin Exp Hypertens A. 13:1991;117-132.
106. Soltis E.E., Soltis T.D., Katovich M.J., Field F.P. Differential effects of phentolamine on the responsiveness of aortic and femoral smooth muscle from normotensive and DOCA/NaCl hypertensive rats. Artery. 13:1986;325-339.
107. Soltis E.E., Iloeje E., Katovich M.J. Dietary potassium, blood pressure and peripheral adrenergic responsiveness in the deoxycorticosterone acetate-salt rat. Clin Exp Hypertens A. 10:1988;447-466.
108. Spector S., Fleisch J.H., Maling H.M., Brodie B.B. Vascular smooth muscle reactivity in normotensive and hypertensive rats. Science. 166:1969;1300-1301.
109. Stiles G.L. Adrenergic receptor responsiveness and congestive heart failure. Am J Cardiol. 67:1991;13C-17C.
110. Suzuki H., Zweifach B.W., Schmid-Schönbein G.W. Vasodilator response of mesenteric arterioles to histamine in spontaneously hypertensive rats. Hypertension. 26:1995;397-406.
111. Takase H., Dohi Y., Kojima M., Sato K. Changes in the endothelial cyclooxygenase pathway in resistance arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 23:1994;326-330.
112. Toal C.B., Leenen F.H.H. Blood pressure responsiveness to isoproterenol during the development of hypertension in conscious, spontaneously hypertensive rats. Blood Vessels. 21:1984;252-256.
113. Trinder D., Phillips P.A., Risvanis J., Stephenson J.M., Johnston C.I. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension. Hypertension. 20:1992;569-574.
114. Triner L., Vulliemoz Y., Verosky M., Manger W. Cyclic adenosine monophosphate and vascular reactivity in spontaneously hypertensive rats. Biochem Pharmacol. 24:1975;743-745.
115. 2 in spontaneously hypertensive rats. J Hypertens. 3:1985;159-165.
116. Ungerer M., Bohm M., Elce J.S., Erdmann D., Lohse M.J. Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circulation. 87:1993;454-463.
117. Van Brummelen P., Buhler F.R., Kiowski W., Amann F.W. Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline. studies in normal subjects Clin Sci. 60:1981;571-577.
118. Van De Voorde J., Leusen I. Endothelium-dependent and independent relaxation of aortic rings from hypertensive rats. Am J Physiol. 250:1986;H711-H717.
119. Vanhoutte P.M. Endothelial dysfunction in hypertension. J Hypertens. 14:1996;S83-S93.
120. Westphal T.C., Han S.-P., Knepfer M.et al. Neuropeptides in Hyperension. role of neuropeptide y and calcitonin gene related peptide Br J Clin Pharmacol. 30:1990;75S-82S.
121. Winquist R.J., Bohr D.F. Structural and functional changes in cerebral arteries from spontaneously hypertensive rats. Hypertension. 5:1983;292-297.
122. Witte K., Parsa-Parsi R., Vobig M., Lemmer B. Mechanisms of the circadian regulation of β-adrenoceptor density and adenylyl cyclase activity in cardiac tissue from normotensive and spontaneously hypertensive rats. J Mol Cell Cardiol. 27:1995;1195-1202.
123. Woodcock E.A., Funder J.W., Johnston C.I. Decreased cardiac β-adrenergic receptor in deoxycorticosterone-salt and renal hypertensive rats. Circ Res. 45:1979;560-565.
124. Wuorela H., Arvola P., Kahohen M., Vapaatalo H. Arterial smooth muscle responses in adult and moderately aged spontaneously hypertensive rats. Pharmacol Toxicol. 74:1994;167-173.
125. 2 receptor in renal medulla of spontaneously hypertensive rats. Am J Hypertens. 3:1990;230-233.